Copyright ©ERS Journals Ltd 2009 CTLA4 gene polymorphisms are associated with chronic bronchitis1 Genetics, GlaxoSmithKline, Research and Development, Research Triangle Park, NC, 8 Brigham and Women's Hospital, Boston, MA, USA. 2 Hospital Universitario Son Dureta, Palma de Mallorca, 3 Fundación Caubet-Cimera, Bunyola, Mallorca, 4 Institut del Tòrax, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain. 5 University of Bergen, Bergen, Norway. 6 University of British Columbia, Vancouver, BC, Canada. 7 Cambridge Institute for Medical Research, Cambridge, UK. 9 A list of the ICGN investigators is given in the Acknowledgements section. CORRESPONDENCE: S. G. Pillai, Glaxo SmithKline R&D, 5 Moore Drive, Research Triangle Park, NC 27709, USA. E-mail: pillaisreekumar{at}yahoo.com Keywords: Chronic bronchitis, chronic obstructive pulmonary disease, genetic association, replication, smoking, tobacco
Received: September 15, 2008
Chronic obstructive pulmonary disease (COPD) is characterised by chronic and progressive dyspnoea, cough and sputum production. T-lymphocytes may play a key role in the pathogenesis of COPD and chronic bronchitis. Cytotoxic T-lymphocyte antigen (CTLA) 4 is a potential candidate gene because it modulates T-cell activation.
Genetic association between nine CTLA4 single nucleotide polymorphisms (SNPs) and chronic bronchitis was assessed in 606 pedigrees (1,896 individuals) from the International COPD Genetics Network (ICGN) population. We then replicated the associations in 342 COPD subjects with chronic bronchitis and 511 COPD subjects without chronic bronchitis from Bergen, Norway. Family-based association tests were used to analyse the ICGN cohort, and a logistic regression model was used for the Bergen cohort.
Six CTLA4 SNPs were significantly associated with chronic bronchitis in the ICGN cohort (0.0079
Thus, CTLA4 is likely to be a genetic determinant of chronic bronchitis among COPD cases.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||